Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Ramy R. Ghali"'
Autor:
Rasha Aboelhassan, Mohamed Emam Sobeih, Mohamed Alm El-Din, Ramy R. Ghali, Ibtessam Saad El-Din, Ola Khorshid, Mohsen Mokhtar, Ahmed Magdy Rabea, Abdelaziz Belal, Hamdy A. Azim, Mohamed Abdullah, Tamer Elnahas, Hesham Tawfik, Sherif Abdelwahab, Amr Abdelaziz Elsaid, Tarek Hashem, Mohamed Mancy, Heba Farag
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Stage III non-small cell lung cancer (NSCLC) being highly heterogeneous requires multimodal therapeutic strategies for optimal management. We present findings on treatment patterns and their associated survival outcomes in patients with s
Externí odkaz:
https://doaj.org/article/e342b075ed5547c6a55a05efdb1a15f1
Autor:
Mai Ezzat Elhawi, Doaa Atef Mohammed, Ramy R. Ghali, Ass. Prof. Dr. Nagy Samy Gobran, Aly M. Azmy, Ass. Prof. Dr. Marwa Mosaad Shakweer
Publikováno v:
QJM: An International Journal of Medicine. 114
Background Locally advanced rectal cancer (LARC) has a high incidence of local and distant relapse even after adequate treatment. The emerging role of neoadjuvant induction chemotherapy may allow initial down staging of the primary tumor, less toxici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eecd48de599f7e4f027a96deec54978
https://doi.org/10.1093/qjmed/hcab103.012
https://doi.org/10.1093/qjmed/hcab103.012
Publikováno v:
QJM: An International Journal of Medicine. 113
Background The prognostic value of Platelet-to-lymphocyte ratio (PLR) in patients with malignant pleural mesothelioma is still indistinct. We conducted this study to assess the prognostic significance of pretreatment PLR in patients with MPM. Aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::019467c6f395cd38dd05a7667ba9a2f3
https://doi.org/10.1093/qjmed/hcaa057.004
https://doi.org/10.1093/qjmed/hcaa057.004
Publikováno v:
QJM: An International Journal of Medicine. 113
Background The treatment of (LARC) is subject to continuous change due to better diagnostic tools, radio therapeutic techniques and chemotherapeutic agents. It is clear, that a multimodality approach is the only way to achieve satisfactory local recu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3744148d86de8223967674c099e3eb7b
https://doi.org/10.1093/qjmed/hcaa057.011
https://doi.org/10.1093/qjmed/hcaa057.011
Publikováno v:
Research in Oncology, Vol 15, Iss 1, Pp 26-30 (2019)
Background: Oncologists are at risk of developing burn out syndrome due to many stressors they may face. Aim: To determine the level of burnout in a cohort of clinical oncologists working in an Egyptian university hospital. Methods: Fifty-two clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3273a7b869fb82ab503da794caa76190
https://doi.org/10.21608/resoncol.2018.3478.1056
https://doi.org/10.21608/resoncol.2018.3478.1056
Publikováno v:
Research in Oncology, Vol 14, Iss 2, Pp 64-69 (2018)
Background: Breast cancer is first cause of cancer-related deaths and it is estimated that 15% of breast cancer patients will develop brain metastases (BM). Its incidence differs according to many factors like molecular subtypes and burden and durati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f58f997b92b9900c4ada929d937d166f
https://doi.org/10.21608/resoncol.2018.3356.1054
https://doi.org/10.21608/resoncol.2018.3356.1054
Publikováno v:
The Egyptian Journal of Hospital Medicine. 68:1308-1315
Background: The male breast cancer (MBC) is a rare disease and represents less than 1% of all malignancies in men and less than 1% of all breast cancers incident. Aim of study: In this descriptive retrospective study we aimed to provide clinico-epide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae8f5c2088362957193e791bf023b2a7
https://doi.org/10.12816/0039667
https://doi.org/10.12816/0039667
Publikováno v:
Cancer Science & Research. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::355f300b77c61c1fbaf61d5409b67782
https://doi.org/10.33425/2639-8478.1021
https://doi.org/10.33425/2639-8478.1021
Publikováno v:
OncoTargets and therapy
Manal El-Hamamsy,1 Ramy R Ghali,2 Amr S Saad,2 Sara M Shaheen,1 Ahmed M Salem1 1Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt; 2Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::debf46bc0837630d669fef6bf25f9ffb
https://doi.org/10.2147/ott.s115631
https://doi.org/10.2147/ott.s115631
Autor:
Khalid Abdel Karim, Manal M. El Mahdy, Amr El Shehaby, Wael A. Reda, Ramy R. Ghali, Reem M Emad, Ahmed M. Nabeel
Publikováno v:
Journal of the Egyptian National Cancer Institute. 30(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f73c2cec110de1cde6f842711e45bf0c
https://pubmed.ncbi.nlm.nih.gov/29691095
https://pubmed.ncbi.nlm.nih.gov/29691095